Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Sun, J. Dong, S. Gong, J. Xie, J. Yan, H.

Human papillomavirus vaccination willingness and influencing factors among women in China: A systematic review and meta-analysis

  • Western Pacific
  • China
  • Children
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Mengistie, B. A. Yirsaw, A. N. Lakew, G. Mekonnen, G. B. Shibabaw, A. A. Chereka, A. A. Kitil, G. W. Wondie, W. T. Abuhay, A. E. Getachew, E.

Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review

  • Africa
  • All age groups
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ la Cruz, R. A. R. D. Flores-Cordova, J. M. Calderon-Hernandez, C. C. Cahuapaza-Gutierrez, N. L. Ccallalli-Ruiz, N. A. Runzer-Colmenares, F. M.

Humoral and Cellular Immune Responses Against SARS-CoV-2 Following COVID-19 Vaccination in Older Adults: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Othman, A. A. Albargy, H.

Humoral immune response to mRNA-based influenza vaccines in older adults: a systematic review and meta-analysis of randomized controlled trials

  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Martinez-Serrano, A. Pulido-Fuentes, M. Notario-Pacheco, B. Palmar-Santos, A. M. Cobo-Cuenca, A. I. Diez-Fernandez, A.

Immunity Awareness-Strategies to Improve the Degree of Acceptance of Vaccines: A Systematic Review

  • All age groups
  • Healthcare workers
  • Parents/caregivers
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Rahimi, H. K. Jasim, A. A. Rezahosseini, O. Harboe, Z. B.

Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Influenza
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Niyati, R. Rezahosseini, O. Ekenberg, C. Larsen, C. S. Harboe, Z. B.

Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review +

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Terekhov, R. P. Svotin, A. A. Korochkina, M. D. Khodyachikh, A. A. Varnavskiy, M. A. Piniaeva, A. N. Ivin, Y. Y. Zhdanov, D. D. Kozlovskaya, L. I. Taldaev, A.

Immunogenicity and safety of polio vaccines in infants: a systematic review of randomized clinical trials

  • Newborn
  • Poliomyelitis
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Montes-Sevilla, L. D. Hernandez-Montes, P. E. Ramirez-Garcia, E. Guzman-Rios, E. D. Flores-Reyes, M. F. Acosta-Gutierrez, G. H. Morales-Hernandez, O. Giron-Perez, M. I.

Immunogenicity and safety of tetravalent dengue vaccines: a systematic review of clinical trials

  • Adults
  • Older adults
  • Dengue
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Chen, Z. Wan, C. Chen, B. Mo, Q. Ju, M. Deng, K. Li, X. Qin, D.

Immunogenicity and safety of the booster COVID-19 vaccine among people with HIV: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...